Contribution of Trimethylamine N-Oxide (TMAO) to Chronic Inflammatory and Degenerative Diseases
Authors:
- Luis A. Constantino-JonapaLCLuis A. Constantino-Jonapa
- Yoshua Espinoza-PalaciosYEYoshua Espinoza-Palacios
- Alma R. Escalona-MontañoAEAlma R. Escalona-Montaño
- Paulina Hernández-RuizPHPaulina Hernández-Ruiz
- Luis M. Amezcua-GuerraLALuis M. Amezcua-Guerra
- Amedeo AmedeiAmedeo Amedei
- María M. Aguirre-GarcíaMAMaría M. Aguirre-García
Top Cited Papers
Open Access
- 2 February 2023
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 11 (2) , 431
Abstract
Trimethylamine N-oxide (TMAO) is a metabolite produced by the gut microbiota and has been mainly associated with an increased incidence of cardiovascular diseases (CVDs) in humans. There are factors that affect one’s TMAO level, such as diet, drugs, age, and hormones, among others. Gut dysbiosis in the host has been studied recently as a new approach to understanding chronic inflammatory and degenerative diseases, including cardiovascular diseases, metabolic diseases, and Alzheimer’s disease. These disease types as well as COVID-19 are known to modulate host immunity. Diabetic and obese patients have been observed to have an increase in their level of TMAO, which has a direct correlation with CVDs. This metabolite is attributed to enhancing the inflammatory pathways through cholesterol and bile acid dysregulation, promoting foam cell formation. Additionally, TMAO activates the transcription factor NF-κB, which, in turn, triggers cytokine production. The result can be an exaggerated inflammatory response capable of inducing endoplasmic reticulum stress, which is responsible for various diseases. Due to the deleterious effects that this metabolite causes in its host, it is important to search for new therapeutic agents that allow a reduction in the TMAO levels of patients and that, thus, allow patients to be able to avoid a severe cardiovascular event. The present review discussed the synthesis of TMAO and its contribution to the pathogenesis of various inflammatory diseases.Keywords
Funding Information
- Universidad Nacional Autónoma de México (IN212422)
This publication has 133 references indexed in Scilit:
- ER stress potentiates insulin resistance through PERK-mediated FOXO phosphorylationGenes & Development, 2013
- Methanomassiliicoccus luminyensis gen. nov., sp. nov., a methanogenic archaeon isolated from human faecesInternational Journal of Systematic and Evolutionary Microbiology, 2012
- The Insulin Receptor Substrate 1 (Irs1) in Intestinal Epithelial Differentiation and in Colorectal CancerPLOS ONE, 2012
- Apolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer DiseaseCold Spring Harbor Perspectives in Medicine, 2012
- Diabetes and CancerDiabetes Care, 2010
- Metabonomic study of biochemical changes in the serum of type 2 diabetes mellitus patients after the treatment of metformin hydrochlorideJournal of Pharmaceutical and Biomedical Analysis, 2009
- The Firmicutes/Bacteroidetes ratio of the human microbiota changes with ageBMC Microbiology, 2009
- Apolipoprotein E: Far More Than a Lipid Transport ProteinAnnual Review of Genomics and Human Genetics, 2000
- Molecular analysis of the trimethylamine N -oxide (TMAO) reductase respiratory system from a Shewanella speciesJournal of Molecular Biology, 1998
- TMAO anaerobic respiration in Escherichia coli: involvement of the tor operonMolecular Microbiology, 1994